Healthcare Transactions: Year in Review

Bass, Berry & Sims PLC

Bass, Berry & Sims PLC

On December 3, 2017, CVS Health Corp. (NYSE: CVS) announced it would purchase health insurer Aetna Inc. (NYSE: AET) for $67.5 billion, a transaction that would be one of the biggest healthcare mergers in the past decade. The proposed deal would combine the largest U.S. drugstore chain with one of the country's largest health insurers. Although consolidation is not a new trend in healthcare, the merger between CVS and Aetna would present a new type of framework, a vertically consolidated company that offers healthcare services through CVS's pharmacies, Minute Clinics and pharmacy benefit manager services, while also providing managed care services to Aetna's millions of plan members.

The transaction raises an intriguing question: is this the beginning of a transformational shift in healthcare? With 2017's failure of the proposed horizontal mergers between health insurance giants still fresh, the CVS–Aetna deal could be the first of many cross-sector mergers. Indeed, only a few days after the announcement, UnitedHealth Group Inc. (NYSE: UNH), the largest U.S. health insurer, announced that it would expand its OptumCare business by acquiring approximately 300 physician practices from DaVita Inc. (NYSE: DVA). If the CVS-Aetna deal is in fact the beginning of a new era, the integration of different healthcare sectors and service lines would be a possible response to the government's emphasis on value-based care, and could serve as a solution to the challenges of traditional reimbursement models.

Managed Care

Even as the Aetna-Humana (NYSE: HUM) and Anthem (NYSE: ANTM)-Cigna (NYSE: CI) mega-mergers faltered as a result of antitrust scrutiny, the managed care industry remained active for mergers and acquisitions in 2017. In a time when the continuing availability of the Affordable Care Act's Medicaid expansion and the repercussions from the Tax Cuts and Jobs Act's repeal of the individual mandate remain uncertain, strategic acquisitions can protect health plans by expanding plan membership and diversifying plan offerings. For example, the $3.75 billion acquisition of Fidelis Care by Centene Corporation (NYSE: CNC), announced in September, will expand Centene's offerings into the State of New York. Already a major presence in the California, Florida and Texas Medicaid markets, Centene's entry into New York is expected to add nearly 1.6 million new members when it closes in the first quarter of 2018. WellCare Health Plans, Inc. (NYSE: WCG) completed several acquisitions in 2017, including the $800 million acquisition of Universal American Corp. in April, which strengthened WellCare's Medicare Advantage membership by adding approximately 119,000 Medicare Advantage members in Texas, New York and Maine. Just a few days later, in May, WellCare announced the completion of its acquisition of assets from Phoenix Health Plan, increasing WellCare's presence in the Arizona Medicaid market. In addition, Anthem, Inc. (NYSE: ANTM) expanded its Medicare Advantage portfolio with the announcement of the acquisition of two Medicare Advantage health insurers in Florida – America's 1st Choice and HealthSun.


In the hospital landscape, 2017 was notable for the consolidation and merger of major nonprofit systems. In December, after more than a year of negotiations, Catholic Health Initiatives and Dignity Health announced a definitive agreement to merge and create a new nonprofit system estimated to have $28.4 billion in combined revenue across 139 hospitals operating in 28 states. The deal is expected to close in the second half of 2018 and is subject to federal, state and church approvals. Advocate Health Care and Aurora Health Care also announced in December their plans to merge to create Advocate Aurora Health, the 10th largest nonprofit, integrated healthcare system in the United States, estimated to have revenues of $11 billion annually and operations in 27 states. Not to be outdone, Ascension is currently in talks with Providence St. Joseph Health about a possible merger to create the largest owner of U.S. hospitals – with the potential for $44.8 billion in combined revenues.

The aforesaid hospital systems cite increased negotiating power with payers and suppliers, as well as the ability to expand access and scale innovation, as the impetus for these mega-mergers. With such large transactions pending, 2018 could be a transformative year for the hospital sector.

Interestingly, in the midst of these mega-mergers, we are also seeing examples of the challenges of expansion and scalability. In 2017, several major healthcare systems divested hospital assets. For example, Community Health Systems, Inc. (NYSE: CYH) recently sold two hospitals in the Houston area and Jourdanton, Texas, to HCA Healthcare, Inc. (NYSE: HCA), which followed the sale of eight hospitals located in Florida, Ohio and Pennsylvania to Steward Health Care System LLC. In addition, Steward added an additional 18 hospitals with the acquisition of Nashville-based IASIS Healthcare LLC in September. Like Community Health Systems, Tenet Healthcare Corporation (NYSE: THC), sold three of its Houston hospitals to HCA, and recently announced the sale of its two Philadelphia-based hospitals – Hahnemann University Hospital and St. Christopher's Hospital for Children – to Paladin Healthcare.

Post-Acute Care — Home Health & Hospice

Tenet also sold certain of its home health and hospice operations in 2017, reflecting Tenet's desire (and a re-emerging trend in healthcare) to refocus on developing core competencies and achieve operational efficiencies through economies of scale. In March, Amedisys Inc. (NYSE: AMED) announced it was acquiring six of Tenet's home health and hospice operations in Arizona, Illinois, Massachusetts and Texas for an undisclosed amount. The home health and hospice sectors continue to grow at a rapid pace and the dominant players – which along with Amedisys include Addus Homecare Corporation (NYSE: ADUS), Almost Family, Inc. (NASDAQ: AFAM) and LHC Group, Inc. (NASDAQ: LHCG) – continue to expand their geographic base, driven by an increasingly aging demographic as baby boomers enter their golden years. Indeed, according to the U.S. Census Bureau, by 2050, those age 65 and older are projected to be 83.7 million; almost double the estimated "senior" population in 2012.

Almost Family and LHC Group are capitalizing on this growing opportunity, as the two entities recently announced their plans to merge, and in so doing, will create a combined company with 781 locations in 36 states, with estimated annual revenues of $1.8 billion. The deal is expected to close in the first half of 2018.

Several other industry players also are capitalizing on the opportunity presented by an aging demographic. In December, a consortium of three companies, Humana Inc. (NYSE: HUM), TPG Capital and Welsh, Carson, Anderson & Stowe (WCAS), announced their plans to purchase Kindred Healthcare, Inc. (NYSE: KND), which operates home health, hospice and community care businesses, long-term acute care hospitals, inpatient rehabilitation facilities and provides contract rehabilitation services. Immediately following the acquisition, the home health, hospice and community care businesses are to be spun off into a separate company, Kindred at Home, which, according to reports, is to be owned 40% by Humana, with Humana having the right to buy the balance from TPG and WCAS over time through a put/call arrangement. This deal is expected to close during the summer of 2018 and represents not only another example of a significant transaction in this sector, but also an example of an insurer crossing sectors and growing more involved in the delivery of care.

Ambulatory Surgery Centers (ASCs)

Not to be forgotten, 2017 started the year with a notable transaction in the ASC space as UnitedHealth's OptumCare announced the acquisition of then publicly traded Surgical Care Affiliates, Inc. for $2.3 billion. The transaction was cited as creating a comprehensive ambulatory care services platform for OptumCare, which includes primary care, urgent care and surgical care services. Following this announcement, in August, KKR & Co. L.P. announced plans to acquire Nashville-based Covenant Surgical Partners, Inc. – an owner and operator of ambulatory surgery centers and physician practices with 37 facilities in 17 states – from DFW Capital Partners, Iroquois Capital Group, PineBridge Investments and other existing shareholders. This announcement came just a day after KKR’s portfolio company, Air Medical Group Holdings, Inc., announced that it would acquire Envision Healthcare Corporation's (NYSE: EVHC) medical transportation subsidiary, American Medical Response, in a $2.4 billion transaction.

Healthcare Information Technology (HIT)

With the shift to value-based payment and regulators' increased emphasis on electronic health record (EHR) management, data, interoperability and cybersecurity, the information technology sector continues to be an attractive target for mergers and acquisitions. The Department of Health and Human Services' policy requirements under the Medicare Access and CHIP Reauthorization Act (MACRA), Merit-based Incentive Payment System (MIPS) and Advanced Alternative Payment Models (APMs) will create a need for new data exchange solutions and interoperability projects. In August, Allscripts Healthcare Solutions, Inc. announced it would buy McKesson's health information technology unit, gaining access to McKesson's Enterprise Information Solutions portfolio, consisting of the Paragon EHR, Star and HealthQuest revenue cycle technologies and OneContent content management tools. Allscripts expects that the $185 million transaction will double its EHR hospital client count in the United States.

Other notable transactions included the announcement of the merger of Medsphere Systems Corporation and Stockell Healthcare Systems, Inc., combining Medsphere's subscription-based EHR system and Stockell's revenue cycle management tools, and the merger of revenue cycle management companies, ZirMed, Inc. and Navicure, Inc. In addition, in June, athenahealth, Inc. (NYSE: ATHN) announced that it had entered into an agreement to acquire Praxify Technologies, Inc., a company that seeks to innovate the way clinicians work with health data through machine learning and natural language processing. This $63 million deal is representative of how companies are using strategic acquisitions to stimulate and improve research and development.

Behavioral Health

The behavioral health and addiction treatment sector also saw major acquisition activity in 2017. In maybe the largest of such acquisitions this year, AAC Holdings, Inc. (Nasdaq: AAC) purchased AdCare, Inc. and its affiliated entities, one of the leading providers of addiction treatment services based in New England. Investment banking firms suggest the fragmented nature of this market, coupled with the growing demand for behavioral healthcare services, has made the industry an attractive investment opportunity. Private equity-backed deals are also fueling activity in this sector. In another notable transaction this year, Summit Behavioral Healthcare, LLC (Summit BHC) – a national provider of addiction treatment and behavioral health services launched by Acadia Healthcare Company, Inc. (NYSE: ACHC), founder Trey Carter and backed by Lee Equity Partners and FFL Partners – acquired two facilities located in Arizona and Tennessee. Behavioral health activity is on an upward trend, and while residential treatment and substance abuse centers were the initial focal point, acquisition interest has emerged in other areas of the behavioral health spectrum as the ongoing opioid and mental health crises are thrust into the national spotlight.

Physician Practice Management

The expansion of private equity investment in the physician practice management sector continued in 2017. Dermatology continued to see activity with the launch of new platforms by Frazier Healthcare Partners (United Derm Partners) and Sheridan Capital Partners (Dermatologists of Central States), among others, while existing private equity-backed companies sought to aggressively execute add-on acquisitions. Radiology also saw growth in 2017. While publicly traded MedNax (NYSE: MD) launched its own radiology division with the acquisition of Tennessee-based Radiology Alliance, Radiology Partners, Inc. – the largest on-site physician-led radiology practice – announced an additional $200 million investment from its existing investor, New Enterprise Associates, Inc. and new investor Future Fund. However, ophthalmology may have seen the most robust activity this past year with Flexpoint Ford, LLC (Southeast Eye Specialists), H.I.G. Capital (Barnet Dulaney Perkins and Southwestern Eye Center), Shore Capital Partners, LLC (EyeSouth Partners), Sterling Partners (Great Lakes MSO), and Waud Capital Partners L.L.C. (United Vision Partners) all investing in platform companies in 2017. Expect to see continued activity in these specialties in 2018, along with emerging specialities such as gastroenterology, orthopaedics and urology.


As always, expansion and consolidation remain significant drivers of transactions in healthcare, and 2017 saw the announcement of several blockbuster mergers. But 2017 also saw the emergence of healthcare companies looking for cross-industry opportunities. As we look ahead to 2018, we can expect this trend to continue.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Bass, Berry & Sims PLC | Attorney Advertising

Written by:

Bass, Berry & Sims PLC

Bass, Berry & Sims PLC on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide

JD Supra Privacy Policy

Updated: May 25, 2018:

JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations.

This Privacy Policy describes how JD Supra, LLC ("JD Supra" or "we," "us," or "our") collects, uses and shares personal data collected from visitors to our website (located at (our "Website") who view only publicly-available content as well as subscribers to our services (such as our email digests or author tools)(our "Services"). By using our Website and registering for one of our Services, you are agreeing to the terms of this Privacy Policy.

Please note that if you subscribe to one of our Services, you can make choices about how we collect, use and share your information through our Privacy Center under the "My Account" dashboard (available if you are logged into your JD Supra account).

Collection of Information

Registration Information. When you register with JD Supra for our Website and Services, either as an author or as a subscriber, you will be asked to provide identifying information to create your JD Supra account ("Registration Data"), such as your:

  • Email
  • First Name
  • Last Name
  • Company Name
  • Company Industry
  • Title
  • Country

Other Information: We also collect other information you may voluntarily provide. This may include content you provide for publication. We may also receive your communications with others through our Website and Services (such as contacting an author through our Website) or communications directly with us (such as through email, feedback or other forms or social media). If you are a subscribed user, we will also collect your user preferences, such as the types of articles you would like to read.

Information from third parties (such as, from your employer or LinkedIn): We may also receive information about you from third party sources. For example, your employer may provide your information to us, such as in connection with an article submitted by your employer for publication. If you choose to use LinkedIn to subscribe to our Website and Services, we also collect information related to your LinkedIn account and profile.

Your interactions with our Website and Services: As is true of most websites, we gather certain information automatically. This information includes IP addresses, browser type, Internet service provider (ISP), referring/exit pages, operating system, date/time stamp and clickstream data. We use this information to analyze trends, to administer the Website and our Services, to improve the content and performance of our Website and Services, and to track users' movements around the site. We may also link this automatically-collected data to personal information, for example, to inform authors about who has read their articles. Some of this data is collected through information sent by your web browser. We also use cookies and other tracking technologies to collect this information. To learn more about cookies and other tracking technologies that JD Supra may use on our Website and Services please see our "Cookies Guide" page.

How do we use this information?

We use the information and data we collect principally in order to provide our Website and Services. More specifically, we may use your personal information to:

  • Operate our Website and Services and publish content;
  • Distribute content to you in accordance with your preferences as well as to provide other notifications to you (for example, updates about our policies and terms);
  • Measure readership and usage of the Website and Services;
  • Communicate with you regarding your questions and requests;
  • Authenticate users and to provide for the safety and security of our Website and Services;
  • Conduct research and similar activities to improve our Website and Services; and
  • Comply with our legal and regulatory responsibilities and to enforce our rights.

How is your information shared?

  • Content and other public information (such as an author profile) is shared on our Website and Services, including via email digests and social media feeds, and is accessible to the general public.
  • If you choose to use our Website and Services to communicate directly with a company or individual, such communication may be shared accordingly.
  • Readership information is provided to publishing law firms and authors of content to give them insight into their readership and to help them to improve their content.
  • Our Website may offer you the opportunity to share information through our Website, such as through Facebook's "Like" or Twitter's "Tweet" button. We offer this functionality to help generate interest in our Website and content and to permit you to recommend content to your contacts. You should be aware that sharing through such functionality may result in information being collected by the applicable social media network and possibly being made publicly available (for example, through a search engine). Any such information collection would be subject to such third party social media network's privacy policy.
  • Your information may also be shared to parties who support our business, such as professional advisors as well as web-hosting providers, analytics providers and other information technology providers.
  • Any court, governmental authority, law enforcement agency or other third party where we believe disclosure is necessary to comply with a legal or regulatory obligation, or otherwise to protect our rights, the rights of any third party or individuals' personal safety, or to detect, prevent, or otherwise address fraud, security or safety issues.
  • To our affiliated entities and in connection with the sale, assignment or other transfer of our company or our business.

How We Protect Your Information

JD Supra takes reasonable and appropriate precautions to insure that user information is protected from loss, misuse and unauthorized access, disclosure, alteration and destruction. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. You should keep in mind that no Internet transmission is ever 100% secure or error-free. Where you use log-in credentials (usernames, passwords) on our Website, please remember that it is your responsibility to safeguard them. If you believe that your log-in credentials have been compromised, please contact us at

Children's Information

Our Website and Services are not directed at children under the age of 16 and we do not knowingly collect personal information from children under the age of 16 through our Website and/or Services. If you have reason to believe that a child under the age of 16 has provided personal information to us, please contact us, and we will endeavor to delete that information from our databases.

Links to Other Websites

Our Website and Services may contain links to other websites. The operators of such other websites may collect information about you, including through cookies or other technologies. If you are using our Website or Services and click a link to another site, you will leave our Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We are not responsible for the data collection and use practices of such other sites. This Policy applies solely to the information collected in connection with your use of our Website and Services and does not apply to any practices conducted offline or in connection with any other websites.

Information for EU and Swiss Residents

JD Supra's principal place of business is in the United States. By subscribing to our website, you expressly consent to your information being processed in the United States.

  • Our Legal Basis for Processing: Generally, we rely on our legitimate interests in order to process your personal information. For example, we rely on this legal ground if we use your personal information to manage your Registration Data and administer our relationship with you; to deliver our Website and Services; understand and improve our Website and Services; report reader analytics to our authors; to personalize your experience on our Website and Services; and where necessary to protect or defend our or another's rights or property, or to detect, prevent, or otherwise address fraud, security, safety or privacy issues. Please see Article 6(1)(f) of the E.U. General Data Protection Regulation ("GDPR") In addition, there may be other situations where other grounds for processing may exist, such as where processing is a result of legal requirements (GDPR Article 6(1)(c)) or for reasons of public interest (GDPR Article 6(1)(e)). Please see the "Your Rights" section of this Privacy Policy immediately below for more information about how you may request that we limit or refrain from processing your personal information.
  • Your Rights
    • Right of Access/Portability: You can ask to review details about the information we hold about you and how that information has been used and disclosed. Note that we may request to verify your identification before fulfilling your request. You can also request that your personal information is provided to you in a commonly used electronic format so that you can share it with other organizations.
    • Right to Correct Information: You may ask that we make corrections to any information we hold, if you believe such correction to be necessary.
    • Right to Restrict Our Processing or Erasure of Information: You also have the right in certain circumstances to ask us to restrict processing of your personal information or to erase your personal information. Where you have consented to our use of your personal information, you can withdraw your consent at any time.

You can make a request to exercise any of these rights by emailing us at or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

You can also manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard.

We will make all practical efforts to respect your wishes. There may be times, however, where we are not able to fulfill your request, for example, if applicable law prohibits our compliance. Please note that JD Supra does not use "automatic decision making" or "profiling" as those terms are defined in the GDPR.

  • Timeframe for retaining your personal information: We will retain your personal information in a form that identifies you only for as long as it serves the purpose(s) for which it was initially collected as stated in this Privacy Policy, or subsequently authorized. We may continue processing your personal information for longer periods, but only for the time and to the extent such processing reasonably serves the purposes of archiving in the public interest, journalism, literature and art, scientific or historical research and statistical analysis, and subject to the protection of this Privacy Policy. For example, if you are an author, your personal information may continue to be published in connection with your article indefinitely. When we have no ongoing legitimate business need to process your personal information, we will either delete or anonymize it, or, if this is not possible (for example, because your personal information has been stored in backup archives), then we will securely store your personal information and isolate it from any further processing until deletion is possible.
  • Onward Transfer to Third Parties: As noted in the "How We Share Your Data" Section above, JD Supra may share your information with third parties. When JD Supra discloses your personal information to third parties, we have ensured that such third parties have either certified under the EU-U.S. or Swiss Privacy Shield Framework and will process all personal data received from EU member states/Switzerland in reliance on the applicable Privacy Shield Framework or that they have been subjected to strict contractual provisions in their contract with us to guarantee an adequate level of data protection for your data.

California Privacy Rights

Pursuant to Section 1798.83 of the California Civil Code, our customers who are California residents have the right to request certain information regarding our disclosure of personal information to third parties for their direct marketing purposes.

You can make a request for this information by emailing us at or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

Some browsers have incorporated a Do Not Track (DNT) feature. These features, when turned on, send a signal that you prefer that the website you are visiting not collect and use data regarding your online searching and browsing activities. As there is not yet a common understanding on how to interpret the DNT signal, we currently do not respond to DNT signals on our site.

Access/Correct/Update/Delete Personal Information

For non-EU/Swiss residents, if you would like to know what personal information we have about you, you can send an e-mail to We will be in contact with you (by mail or otherwise) to verify your identity and provide you the information you request. We will respond within 30 days to your request for access to your personal information. In some cases, we may not be able to remove your personal information, in which case we will let you know if we are unable to do so and why. If you would like to correct or update your personal information, you can manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard. If you would like to delete your account or remove your information from our Website and Services, send an e-mail to

Changes in Our Privacy Policy

We reserve the right to change this Privacy Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our Privacy Policy will become effective upon posting of the revised policy on the Website. By continuing to use our Website and Services following such changes, you will be deemed to have agreed to such changes.

Contacting JD Supra

If you have any questions about this Privacy Policy, the practices of this site, your dealings with our Website or Services, or if you would like to change any of the information you have provided to us, please contact us at:

JD Supra Cookie Guide

As with many websites, JD Supra's website (located at (our "Website") and our services (such as our email article digests)(our "Services") use a standard technology called a "cookie" and other similar technologies (such as, pixels and web beacons), which are small data files that are transferred to your computer when you use our Website and Services. These technologies automatically identify your browser whenever you interact with our Website and Services.

How We Use Cookies and Other Tracking Technologies

We use cookies and other tracking technologies to:

  1. Improve the user experience on our Website and Services;
  2. Store the authorization token that users receive when they login to the private areas of our Website. This token is specific to a user's login session and requires a valid username and password to obtain. It is required to access the user's profile information, subscriptions, and analytics;
  3. Track anonymous site usage; and
  4. Permit connectivity with social media networks to permit content sharing.

There are different types of cookies and other technologies used our Website, notably:

  • "Session cookies" - These cookies only last as long as your online session, and disappear from your computer or device when you close your browser (like Internet Explorer, Google Chrome or Safari).
  • "Persistent cookies" - These cookies stay on your computer or device after your browser has been closed and last for a time specified in the cookie. We use persistent cookies when we need to know who you are for more than one browsing session. For example, we use them to remember your preferences for the next time you visit.
  • "Web Beacons/Pixels" - Some of our web pages and emails may also contain small electronic images known as web beacons, clear GIFs or single-pixel GIFs. These images are placed on a web page or email and typically work in conjunction with cookies to collect data. We use these images to identify our users and user behavior, such as counting the number of users who have visited a web page or acted upon one of our email digests.

JD Supra Cookies. We place our own cookies on your computer to track certain information about you while you are using our Website and Services. For example, we place a session cookie on your computer each time you visit our Website. We use these cookies to allow you to log-in to your subscriber account. In addition, through these cookies we are able to collect information about how you use the Website, including what browser you may be using, your IP address, and the URL address you came from upon visiting our Website and the URL you next visit (even if those URLs are not on our Website). We also utilize email web beacons to monitor whether our emails are being delivered and read. We also use these tools to help deliver reader analytics to our authors to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

Analytics/Performance Cookies. JD Supra also uses the following analytic tools to help us analyze the performance of our Website and Services as well as how visitors use our Website and Services:

  • HubSpot - For more information about HubSpot cookies, please visit
  • New Relic - For more information on New Relic cookies, please visit
  • Google Analytics - For more information on Google Analytics cookies, visit To opt-out of being tracked by Google Analytics across all websites visit This will allow you to download and install a Google Analytics cookie-free web browser.

Facebook, Twitter and other Social Network Cookies. Our content pages allow you to share content appearing on our Website and Services to your social media accounts through the "Like," "Tweet," or similar buttons displayed on such pages. To accomplish this Service, we embed code that such third party social networks provide and that we do not control. These buttons know that you are logged in to your social network account and therefore such social networks could also know that you are viewing the JD Supra Website.

Controlling and Deleting Cookies

If you would like to change how a browser uses cookies, including blocking or deleting cookies from the JD Supra Website and Services you can do so by changing the settings in your web browser. To control cookies, most browsers allow you to either accept or reject all cookies, only accept certain types of cookies, or prompt you every time a site wishes to save a cookie. It's also easy to delete cookies that are already saved on your device by a browser.

The processes for controlling and deleting cookies vary depending on which browser you use. To find out how to do so with a particular browser, you can use your browser's "Help" function or alternatively, you can visit which explains, step-by-step, how to control and delete cookies in most browsers.

Updates to This Policy

We may update this cookie policy and our Privacy Policy from time-to-time, particularly as technology changes. You can always check this page for the latest version. We may also notify you of changes to our privacy policy by email.

Contacting JD Supra

If you have any questions about how we use cookies and other tracking technologies, please contact us at:

- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.